Physician profile

Seth Michael Woodruff

Psychiatric/Mental Health (Nurse Practitioner) · Lafayette, LA

NPI 1760794408

$10,466.36

in general payments reported to CMS, 2019-2025

29 companies · $3,250 in 2025

The $3,250 reported for 2025 was more than what 97% of Psychiatric/Mental Health (Nurse Practitioner) providers received nationally (typical 2025 total: $257).

See the full distribution for Psychiatric/Mental Health (Nurse Practitioner)

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$7,629.58
Education$48.84

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Abbvie INC. $1,444.78 2021-2025
Alkermes, INC. $1,126.66 2021-2025 Aristada, Lybalvi, Vivitrol
Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) $1,063.70 2021-2025 Caplyta
Otsuka America Pharmaceutical, INC. $818.74 2021-2025 Rexulti, Abilify Asimtufii, Abilify Maintena
Janssen Pharmaceuticals, INC $772.48 2021-2025 Spravato, Invega Sustenna, Invega Trinza
Corium, LLC $763.63 2021-2025 Azstarys, Azstarys
Neurocrine Biosciences, INC. $642.06 2021-2025 Ingrezza
Tris Pharma INC $593.88 2021-2025 Dyanavel Xr
Supernus Pharmaceuticals, INC. $414.54 2022-2025 Qelbree, Qelbree
Takeda Pharmaceuticals U.S.A., INC. $403.40 2021-2025 Trintellix
Braeburn INC. $363.24 2024-2025 Brixadi
Vanda Pharmaceuticals INC. $296.24 2021-2025 Fanapt
Teva Pharmaceuticals USA, INC. $285.70 2021-2025 Uzedy, Austedo Xr
Bausch Health US, LLC $201.89 2021-2023 Wellbutrin, Aplenzin
Axsome Therapeutics, INC. $186.50 2023-2025 Auvelity, Sunosi
Show all 29 companies
CompanyGeneral paymentsYearsTop products
Lundbeck LLC $149.61 2022-2025 Rexulti
Ironshore Pharmaceuticals INC. $143.55 2022-2024 Jornay Pm
Noven Therapeutics, LLC $136.86 2024-2025 Xelstrym, Secuado
Sunovion Pharmaceuticals INC. $132.55 2021-2022
Collegium Pharmaceutical, INC. $115.92 2025 Jornay Pm
Idorsia Pharmaceuticals US INC $98.45 2022-2025 Quviviq, Quviviq
Neos Therapeutics, LP $89.71 2023-2025 Adzenys Xr-Odt, Exxua
Adlon Therapeutics L.P. $55.31 2021
Glaxosmithkline, LLC. $42.30 2022
Eisai INC. $36.12 2021-2022
Allergan, INC. $27.35 2021
Sage Therapeutics, LLC $22.74 2025 Zurzuvae
Avanir Pharmaceuticals, INC. $22.34 2022
Indivior INC. $16.11 2023 Sublocade

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Seth Michael Woodruff

$10,466.36

in general payments reported 2019-2025

Years
2021-2025
Top company
Abbvie INC.
Context
The $3,250 reported for 2025 was more than what 97% of Psychiatric/Mental Health (Nurse Practitioner) providers received nationally (typical 2025 total: $257).

https://glasscript.com/doctor/11171586/seth-michael-woodruff

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.